Menu
Logo

Novel imaging in non-metastatic castration-resistant prostate cancer (nmCRPC)

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.
Manage cookie settings
Dr. Boris Hadaschik, explains the roles and limitations of novel imaging technologies in non-metastatic castration-resistant prostate cancer. (6:08 min) ►

EM-30317

Læs pligttekst her ERLEADA® (apalutamide)